# PHASE-011 — Production Dark Deploy Report

## Status

**BLOCKED DURING IMMUTABLE FRONTEND BUILD**

Stage E approved and Stage F began from the pinned source
`main@8139fc4c65c3cdacc9d7467285f3b3c4b977c7cb`.

- Source archive SHA-256:
  `70cf583004b29d39e42f0570614da69026effb6b279764708fad428ecbc46e65`.
- Backend image build: **APPROVED**; image tag is pinned to the full source SHA
  and image ID is
  `sha256:cc9c90e36696d9983a18e07b3608753e0ebbecb3402991755a9969814fc3da6b`.
- Frontend image build: **FAILED** during `next build`.
- Failure: `components/BackboneSelector.tsx` imports
  `../lib/backboneStore`, which is absent from the authorized source tree.
- The build also reported the existing Node-engine warning for `pdfjs-dist` and
  dependency audit findings; these were not corrected in this phase.

Because the combined build command failed, `docker compose up` was not reached.
No backend/frontend production containers were created, no internal endpoint
was activated and no partial application deploy occurred. Correcting the
authorized source requires a separate functional phase and new immutable SHA.

## Frontend blocker diagnosis gate

Repository history and all available refs show that `backboneStore` never
existed; the broken import was present in the initial commit. The active call
graph is `SwitchAdmin -> BackboneSelector`, so the component is not dead. The
canonical backbone persistence contract is the existing
`GET/POST /api/infra/backbone` handler, also used by the Backbone page.

A repository-only minimal API reconnection was evaluated locally. `npm ci`
succeeded, and the original `backboneStore` resolution error disappeared.
However, the same production build then stopped at an unrelated missing module:
`components/layout/AppShell.tsx` imports absent
`@/providers/SkiaContextProvider`.

This is the gate's explicit broader-incomplete-integration hard stop. The
candidate Backbone change was withdrawn and was neither committed nor deployed.
No application source fix is claimed approved. Existing dependency audit output
remained 1 moderate and 6 high findings; no dependency mutation was authorized.
